Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma.

Leukemia & lymphoma - 1 Nov 2007

Abazis-Stamboulieh Danai, Oikonomou Pagona, Papadoulis Nikolaos, Panayiotidis Panayiotis, Vrakidou Efimia, Tsezou Aspasia

Abstract excerpt

Interleukin-1 (IL-1) is a cytokine involved in the maturation and proliferation of B cells and plays a significant role in the development of lytic bone lesions, a major clinical feature of multiple myeloma (MM) patients. Genes that regulate products involved in the immune system are highly polymorphic and contribute to inter-individual differences that can influence the genetic predisposition and progression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Linkage

Share to Greece

Share to Interleukin 1 Receptor Antagonist Protein

Share to Interleukin-1alpha

Share to Interleukin-1beta

Share to Multiple Myeloma

Source

Identifiers

PMID: 17926179
DOI: 10.1080/10428190701615892

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma.PMID 17926179Read ↗

A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma.Semantic proximity Read ↗

Role of cytokines in multiple myeloma: IL-1RN and IL-4 VNTR polymorphisms.Semantic proximity Read ↗

Common variants in genes that mediate immunity and risk of multiple myeloma.Semantic proximity Read ↗

Genetic polymorphisms and multiple myeloma risk: a meta-analysis.Semantic proximity Read ↗

Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.Semantic proximity Read ↗

Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myelomaSemantic proximity Read ↗

Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib.Semantic proximity Read ↗

Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma.Semantic proximity Read ↗

The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT.Semantic proximity Read ↗

Effect of Cytokine Genes in the Pathogenesis and on the Clinical Parameters for the Treatment of Multiple Myeloma.Semantic proximity Read ↗

Analysis of polymorphism at site -174 G/C of interleukin-6 promoter region in multiple myeloma.Semantic proximity Read ↗

Genetic factors influencing the risk of multiple myeloma bone disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.